Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06263738 · ClinicalTrials.gov registry record · NA

Cold and Heat Investigation to Lower Levels of Depression

A NA study of Depression and Mood Disorders, sponsored by Barry Sandler.

Recruiting
Registry status
NA
Development phase
162
Enrollment target
1
Study location

NCT06263738 is a NA study of Depression and Mood Disorders that is actively recruiting participants, run by Barry Sandler. The registered enrollment target is 162 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06263738, a NA study of Depression and Mood Disorders, is actively recruiting participants, sponsored by Barry Sandler.

RECRUITING
Registry status
NA
Development phase
162 participants
Enrollment target
1
Study location

Study Summary

This study will recruit 112 medically healthy adults (aged 18-65) currently experiencing depressive symptoms to be randomized to receive either a single Whole Body Hyperthermia (heat therapy) treatment or a Whole Body Hyperthermia treatment followed by a cold water plunge. Participants will complete a baseline assessment of their depressive symptoms as well as 1-week and 2-week post-treatment followup assessments.

Interventions

  • PROCEDURE Whole Body Hyperthermia
  • PROCEDURE Cold Water Plunge

Study Locations (1)

Colorado

  • Vail Health Behavioral Health Innovation Center - Edwards

Trial Details

FieldValue
Enrollment Target 162 participants
Start Date 2024-05-14
Est. Completion 2027-04-01
Phase NA

Sponsor

Barry Sandler

1 total trials

What the Registry Record Tells You About NCT06263738

The ClinicalTrials.gov registry entry for NCT06263738 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 162 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 786-participant average among 679 other Depression trials with a reported enrollment target (79% lower). The listed sponsor is Barry Sandler, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Depression appearing as the primary indexed condition, and to 2 interventions - of which Whole Body Hyperthermia is the first listed.

NCT06263738 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.

Frequently Asked Questions

What is clinical trial NCT06263738 about?

NCT06263738 is a clinical study titled "Cold and Heat Investigation to Lower Levels of Depression". This study will recruit 112 medically healthy adults (aged 18-65) currently experiencing depressive symptoms to be randomized to receive either a single Whole Body Hyperthermia (heat therapy) treatment or a Whole Body Hyperthermia treatment followed by a cold water plunge. Participants will complete...

What is the current status of trial NCT06263738?

This trial is currently recruiting. It is a NA study. The enrollment target is 162 participants. The study started on 2024-05-14. Estimated completion is 2027-04-01.

What conditions does trial NCT06263738 study?

This clinical trial studies the following conditions: Depression, Mood Disorders, Healthy (Controls).

What interventions are being tested in trial NCT06263738?

The interventions under investigation include: Whole Body Hyperthermia (PROCEDURE), Cold Water Plunge (PROCEDURE).

Who is sponsoring clinical trial NCT06263738?

This trial is sponsored by Barry Sandler, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06263738 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.